Skip to main content
Institutional deep-dive - valuation, health, statements

Financial Analysis

Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data

Fundamentals

Fortrea Holdings Inc. FTRE

· Healthcare · Services-Medical Laboratories

FY2025 10-K, filed 2026-02-26
SEC EDGAR

Filing evidence summary

Mixed evidenceCoverage 5/5 core metrics

Operating margin changed -26.0 percentage points from the prior annual period.

Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.

Evidence signals

  • Operating margin compressed

    Operating margin changed -26.0 percentage points from the prior annual period.

    Why this surfaced

    Direction threshold: more than +1 percentage point constructive; below -1 point caution. Period end 2025-12-31.

  • 3 filing risk checks flagged

    Flagged areas: Solvency & liquidity.

    Why this surfaced

    The full financial analysis shows each value, threshold, and sector limitation.

  • Revenue was broadly stable

    Latest reported annual revenue changed +1.0% from the prior reported annual observation.

    Why this surfaced

    Direction threshold: above +2% constructive; below -2% caution; otherwise monitor. This is not labeled one-year growth when filing periods have a gap. Period end 2025-12-31.

  • Free cash flow was positive

    Latest reported free cash flow was $88M.

    Why this surfaced

    Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2025-12-31.

Core trend metrics

Latest annual revenue growth
+1.0%
as of 2025-12-31
Latest annual operating margin
-32.0%
as of 2025-12-31
Free cash flow
$88M
as of 2025-12-31
Debt / equity
1.86x
as of 2025-12-31
ROIC snapshot
-44.1%
period varies

Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.

Where to look next

Risk checks

3of 8 rule-based checks flagged
  • Solvency & liquidity

Financial movement

  • Cash→ flat
  • Long-term debt→ flat
  • Inventory→ flat
  • Receivables→ flat
  • Current assets→ flat

Source & freshness

Source
SEC EDGAR XBRL
Fetched
2026-09-06
Latest period end
2025-12-31
Filings
EDGAR ↗

Reported segment mix

figures as filed · share of the filed sum · change vs the prior period in the same filing
Fiscal year ending 2025-12-3110-K filed 2026-02-26prior period 2024-12-31 from the same filingView filing
By business segment
Operating income
  • Clinical Services Segment-$873M
    100.0%
    +439.0% yoy

Members sum to the consolidated -$873M for this period.

By geography
Revenue
  • North America$1.29B
    47.4%
    +1.6% yoy
  • Europe$852M
    31.3%
    +6.5% yoy
  • Other Geographical Areas$582M
    21.4%
    -7.1% yoy

Members sum to the consolidated $2.72B for this period.

Latest quarter
Quarter ending 2026-06-3010-Q filed 2026-07-29prior period 2026-03-31 from the same filingView filing
  • North America$320M
    47.1%
    no prior
  • Europe$220M
    32.4%
    no prior
  • Other Geographical Areas$139M
    20.5%
    no prior

Change is against the same quarter a year earlier, as reported in the same 10-Q.

Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.

Peer percentiles

latest fiscal year ending 2025-12-31 · among 4,104 US-listed filers · 318 in Healthcare
MetricValuevs all filersvs sector
Revenue
latest fiscal-year revenue as filed
$2.7B
71stof 3,301
top third
78thof 291
top third
Revenue growth
latest fiscal-year revenue vs the prior fiscal year
1.0%
32ndof 3,135
bottom third
25thof 277
bottom third
Operating margin
operating income ÷ revenue
-32.0%
23rdof 2,819
bottom third
32ndof 280
bottom third
Net margin
net income ÷ revenue
-36.2%
21stof 3,263
bottom third
31stof 290
bottom third
Free-cash-flow margin
(operating cash flow − |capex|) ÷ revenue
3.2%
45thof 2,679
middle third
54thof 261
middle third
Return on equity
net income ÷ stockholders' equity (positive equity only)
-175.0%
7thof 3,577
bottom third
13thof 291
bottom third
Stock comp ÷ revenue
stock-based compensation ÷ revenue · lower is ranked higher
2.7%
46thof 2,895
middle third
55thof 272
middle third
Net debt ÷ operating cash flow
net debt ÷ operating cash flow (OCF > 0) · lower is ranked higher
7.7×
15thof 1,547
bottom third
14thof 116
bottom third
Cash-flow accrual ratio
(net income − operating cash flow) ÷ average total assets · lower is ranked higher
-34.9%
96thof 3,291
top third
96thof 243
top third
Balance-sheet accrual ratio
change in net operating assets ÷ average net operating assets · lower is ranked higher
-45.9%
91stof 2,805
top third
89thof 213
top third

Each filer's latest fiscal year as stored by the nightly crawl; fiscal year ends differ across the universe. A metric ranks only filers for which it is computable from filed facts. Ties split; a rank reads "better than N% of filers" in the metric's own direction. Descriptive and educational, not a rating.

Earnings quality

latest fiscal year ending 2025-12-31 · accruals and cash conversion as filed
Cash conversion
-
operating cash flow ÷ net income, latest fiscal year
Cash-flow accrual ratio
-34.9%
(net income − operating cash flow) ÷ average total assets
Balance-sheet accrual ratio
-45.9%
change in net operating assets ÷ average net operating assets
Cash-backed years
4 of 5
fiscal years where operating cash flow met or exceeded net income
Mean cash conversion
1.09×
across the stored fiscal years with positive net income

Per fiscal year from filed facts: cash conversion = operating cash flow / net income (net income > 0); cash-flow accrual ratio = (net income - operating cash flow) / average total assets; balance-sheet accrual ratio = change in net operating assets / average net operating assets, NOA = (assets - cash) - (liabilities - debt). Descriptive; a missing input yields a missing ratio. High accrual ratios and cash conversion well below one are the measures the accruals literature associates with less persistent earnings; they are screens to read the cash-flow statement with, not conclusions. The per-year series is part of Pro risk analysis.

Point-in-time ledger

first-reported vs latest filing · periods since 2020-01-01 · 24 changed periods
Line itemPeriodFirst reportedLatest filingChangeFilings
Net income
NetIncomeLoss
fiscal year 2023-12-31-$3.4M
10-K 2024-03-13
-$25.2M
10-K 2026-02-26
-641.2%first · latest · 4 filings carry it
Operating income
OperatingIncomeLoss
fiscal year 2023-12-31$63.1M
10-K 2024-03-13
$32M
10-K 2026-02-26
-49.3%first · latest · 4 filings carry it
Net income
NetIncomeLoss
quarter 2023-03-31$17.4M
10-Q 2023-08-14
$12.5M
10-Q 2024-11-08
-28.2%first · latest · 5 filings carry it
Operating income
OperatingIncomeLoss
quarter 2023-09-30$14M
10-Q 2023-11-13
$10.3M
10-Q 2024-11-08
-26.4%first · latest · 3 filings carry it
Operating income
OperatingIncomeLoss
fiscal year 2022-12-31$236M
10-K 2024-03-13
$187M
10-K 2025-03-03
-20.7%first · latest · 3 filings carry it
Goodwill
Goodwill
balance at 2022-12-31$2B
10-Q 2023-08-14
$1.71B
10-K 2025-03-03
-14.5%first · latest · 6 filings carry it
Goodwill
Goodwill
balance at 2023-06-30$2.03B
10-Q 2023-08-14
$1.74B
10-Q 2024-08-12
-14.3%first · latest
Goodwill
Goodwill
balance at 2023-12-31$2.03B
10-K 2024-03-13
$1.74B
10-K 2026-02-26
-14.3%first · latest · 9 filings carry it
Deferred revenue (current)
ContractWithCustomerLiabilityCurrent
balance at 2023-12-31$241M
10-K 2024-03-13
$214M
10-K 2025-03-03
-11.3%first · latest · 5 filings carry it
Net income
NetIncomeLoss
quarter 2023-06-30$28.3M
10-Q 2023-08-14
$30.8M
10-Q 2024-11-08
+8.8%first · latest · 5 filings carry it
Revenue
RevenueFromContractWithCustomerExcludingAssessedTax
fiscal year 2023-12-31$3.11B
10-K 2024-03-13
$2.84B
10-K 2026-02-26
-8.6%first · latest · 4 filings carry it
Revenue
RevenueFromContractWithCustomerExcludingAssessedTax
quarter 2023-06-30$793M
10-Q 2023-08-14
$725M
10-Q 2024-08-12
-8.6%first · latest · 3 filings carry it
Revenue
RevenueFromContractWithCustomerExcludingAssessedTax
fiscal year 2022-12-31$3.1B
10-K 2024-03-13
$2.84B
10-K 2025-03-03
-8.4%first · latest · 3 filings carry it
Revenue
RevenueFromContractWithCustomerExcludingAssessedTax
quarter 2023-09-30$776M
10-Q 2023-11-13
$714M
10-Q 2024-11-08
-8.1%first · latest · 3 filings carry it
Net income
NetIncomeLoss
quarter 2023-09-30-$13.1M
10-Q 2023-11-13
-$14M
10-Q 2024-11-08
-6.9%first · latest · 3 filings carry it
Operating income
OperatingIncomeLoss
quarter 2023-06-30$33.8M
10-Q 2023-08-14
$31.6M
10-Q 2024-08-12
-6.5%first · latest · 3 filings carry it
Intangibles
IntangibleAssetsNetExcludingGoodwill
balance at 2023-12-31$771M
10-K 2024-03-13
$728M
10-K 2025-03-03
-5.6%first · latest · 5 filings carry it
Operating cash flow
NetCashProvidedByUsedInOperatingActivities
fiscal year 2022-12-31$87.5M
10-K 2024-03-13
$82.7M
10-K 2025-03-03
-5.5%first · latest · 3 filings carry it
Net income
NetIncomeLoss
fiscal year 2022-12-31$193M
10-K 2024-03-13
$186M
10-K 2025-03-03
-3.5%first · latest · 3 filings carry it
Depreciation and amortization
DepreciationDepletionAndAmortization
fiscal year 2023-12-31$96.4M
10-K 2024-03-13
$98M
10-K 2026-02-26
+1.7%first · latest · 4 filings carry it
Stockholders' equity
StockholdersEquity
balance at 2023-12-31$1.74B
10-K 2024-03-13
$1.71B
10-K 2026-02-26
-1.4%first · latest · 9 filings carry it
Depreciation and amortization
DepreciationDepletionAndAmortization
fiscal year 2022-12-31$92.7M
10-K 2024-03-13
$93.6M
10-K 2025-03-03
+1.0%first · latest · 3 filings carry it
Operating cash flow
NetCashProvidedByUsedInOperatingActivities
fiscal year 2023-12-31$167M
10-K 2024-03-13
$168M
10-K 2026-02-26
+0.6%first · latest · 4 filings carry it
Total assets
Assets
balance at 2023-12-31$4.36B
10-K 2024-03-13
$4.33B
10-K 2025-03-03
-0.6%first · latest · 5 filings carry it

First filing reporting each period vs the latest filing carrying it (10-K and 10-Q only, periods since 2020, the extractor's winning tag per concept); a change under 0.5% is treated as rounding. A change can be a restatement, a reclassification or a re-tagging in a later comparative column; the two filings are linked so the reader can see which. Descriptive, not a verdict.

Notes by disclosure type

debt, leases, revenue, segments, contingencies, taxes and more · the filer's own words
Latest quarterly report10-Q FY2026 Q2 · filed 20260729View filing
Commitments and contingencies · 5,330 characters as filed

COMMITMENTS AND CONTINGENT LIABILITIES The Company is involved from time to time in various claims and legal actions arising in the ordinary course of business. These matters may include commercial and contract disputes, employee-related matters, and professional liability claims. In accordance with FASB ASC 450, Contingencies , the Company establishes reserves for claims and legal actions when those matters present loss contingencies that are both probable and estimable. When loss contingencies are not both probable and estimable, the Company does not establish reserves. The outcomes of such proceedings are inherently unpredictable and subject to significant uncertainties. When the Company determines that it has a meritorious defense to any claims asserted, the Company defends itself vigorously; however the Company also considers and enters into discussions regarding settlement of disputes, and may enter into settlement agreements, if in managements judgment, it is in the best interest of the Company to do so. For the three and six months ended June 30, 2025, the Company recorded legal expenses of $ and $1.9 related to the settlement of legal matters initiated prior to the Spin. Legal settlement expenses for the three and six months ended June 30, 2026 we re not significant. The Company does not believe that any liabilities resulting from claims and legal actions will have a material effect on its financial condition, results of operations or cash flows. On July 6, 2026, The

CommitmentsAndContingenciesDisclosureTextBlock · excerpt; the full note is in the filing

Debt · 3,778 characters as filed

DEBT The current portion of long-term debt consisted of the following: June 30, 2026 December 31, 2025 Current portion of senior secured term loan A facility due 2028 $ 17.3 $ 4.8 Debt issuance discount and fees (0.2) Total current portion of long-term debt $ 17.1 $ 4.8 Long-term debt consisted of the following: June 30, 2026 December 31, 2025 7.5% senior notes due 2030 $ 494.3 $ 494.3 Senior secured term loan A due 2028 400.0 412.5 Senior secured term loan B due 2030 154.7 154.7 Debt issuance discount and fees (11.8) (13.5) Total long-term debt $ 1,037.2 $ 1,048.0 Senior Notes On June 27, 2023, the Company issued $570.0 aggregate principal amount of 7.50% senior notes due 2030 (the Notes). Interest on these notes is payable semi-annually on January 1 and July 1 of each year. Net proceeds from the offering of the Notes were $560.2 after deducting expenses of the offering. Credit Facilities On June 30, 2023, Fortrea entered into a credit agreement (as amended, the Credit Agreement) providing for (i) a senior secured revolving credit facility in the principal amount of up to $450.0; (ii) a five-year $500.0 first lien senior secured term A loan facility; and (iii) a seven-year $570.0 first lien senior secured term B loan facility. The initial revolving facility includes a $75.0 swingline sub-facility and a $75.0 letter of credit sub-facility. The Company drew on the term loan A and term loan B on June 30, 2023. The net proceeds received for the term A and term B loans were $491.

DebtDisclosureTextBlock · excerpt; the full note is in the filing

Revenue disaggregation · 519 characters as filed

The Companys revenues by geography for the three and six months ended June 30, 2026 and 2025 are as follows: Three Months Ended June 30, 2026 Three Months Ended June 30, 2025 North America Europe Other Total North America Europe Other Total Revenues $ 319.7 $ 219.7 $ 138.8 $ 678.2 $ 344.3 $ 218.7 $ 147.3 $ 710.3 Six Months Ended June 30, 2026 Six Months Ended June 30, 2025 North America Europe Other Total North America Europe Other Total Revenues $ 616.5 $ 433.6 $ 264.6 $ 1,314.7 $ 653.8 $ 419.0 $ 288.8 $ 1,361.6

DisaggregationOfRevenueTableTextBlock · excerpt; the full note is in the filing

Share-based compensation · 873 characters as filed

STOCK COMPENSATION PLANS The Company granted 0.4 and 2.3 restricted stock units, respectively, during the three and six months ended June 30, 2026 with weighted average grant date fair values of $15.45 and $10.54 per share. The Company granted and 0.9 performance stock units, respectively, during the three and six months ended June 30, 2026 with weighted average grant date fair values of $ and $11.66 per share. Total stock-based compensation expense and the associated income tax benefits recognized by the Company in the condensed consolidated statements of operations were as follows: Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025 Direct costs $ 8.2 $ 17.2 $ 16.3 $ 28.8 Selling, general and administrative expenses 4.4 5.5 7.7 8.5 Total stock compensation expense $ 12.6 $ 22.7 $ 24.0 $ 37.3 Income tax benefits $ 2.0 $ 3.1 $ 3.9 $ 5.4

DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock · excerpt; the full note is in the filing

Income taxes · 1,851 characters as filed

INCOME TAXES For the three months ended June 30, 2026 and 2025, the Company recognized income tax expenses of $12.0 and $4.2, respectively, which resulted in effective tax rates of (1000.0)% and (1.1)%, respectively. The effective tax rate for the three months ended June 30, 2026 was lower than the Companys statutory tax rate primarily due to an increase in valuation allowance, non-deductible compensation expenses, earnings taxed in jurisdictions with higher tax rates and withholding taxes for 2026 non-U.S. earnings that are not permanently reinvested. For the three months ended June 30, 2025, the Companys effective tax rate was lower than the Companys statutory tax rate primarily due to impairment of goodwill that has no tax benefit, an increase in valuation allowance of deferred tax assets, BEAT, non-deductible compensation expenses and withholding taxes for 2025 non-U.S. earnings that are not permanently reinvested. For the six months ended June 30, 2026 and 2025, the Company recognized income tax expense of $23.3 and $19.1, respectively, which resulted in effective tax rates of (172.6)% and (2.1)%, respectively. The effective tax rate for the six months ended June 30, 2026 was lower than the Companys statutory tax rate primarily due to an increase in valuation allowance, non-deductible compensation expenses, earnings taxed in jurisdictions with higher tax rates and withholding taxes for 2026 non-U.S. earnings that are not permanently reinvested. For the six months ended J

IncomeTaxDisclosureTextBlock · excerpt; the full note is in the filing

New accounting pronouncements · 2,440 characters as filed

Recently Issued and Adopted Accounting Standards In November 2024, the Financial Accounting Standards Board (FASB) issued ASU 2024-03, Income StatementReporting Comprehensive IncomeExpense Disaggregation Disclosures (Subtopic 220-40), Disaggregation of Income Statement Expenses. The new guidance requires disclosure of certain costs and expenses in the notes to the financial statements. This guidance is effective for fiscal years beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The disclosures required under the guidance can be applied either prospectively to financial statements issued for reporting periods after the effective date or retrospectively to any or all periods presented in the financial statements. The Company is currently evaluating the impact this guidance will have on its financial statement disclosures. In September 2025, the FASB issued ASU 2025-06, IntangiblesGoodwill and OtherInternal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. The new guidance simplifies the accounting for internally developed software by replacing the existing phase-based capitalization model with a principles-based approach that focuses on managements authorization and the probability of project completion. The guidance is effective for fiscal years beginning after December 15, 2027, including interim periods within those fiscal years. Entities may apply t

NewAccountingPronouncementsPolicyPolicyTextBlock · excerpt; the full note is in the filing

Restructuring · 1,441 characters as filed

RESTRUCTURING AND OTHER CHARGES In the fourth quarters of 2024 and 2025, the Company approved restructuring plans to streamline its operations and eliminate redundant positions. These plans, which relate primarily to severance benefits, were accounted for under ASC 712, Compensation - Nonretirement Postemployment Benefits . Actions under these restructuring plans are expected to continue through 2026. The following represents the Companys restructuring accrual activities for the periods indicated: Severance and Other Employee Costs Facility and Other Costs Total Balance as of December 31, 2025 $ 22.9 $ 0.5 $ 23.4 Restructuring charges 5.7 1.1 6.8 Cash payments and other adjustments (21.1) (1.1) (22.2) Balance as of June 30, 2026 $ 7.5 $ 0.5 $ 8.0 Severance and Other Employee Costs Facility and Other Costs Total Balance as of December 31, 2024 $ 23.1 $ 0.6 $ 23.7 Restructuring charges 8.8 1.4 10.2 Cash payments and other adjustments (17.9) (1.4) (19.3) Balance as of June 30, 2025 $ 14.0 $ 0.6 $ 14.6 The current portion of the restructuring liabilities is included in the condensed consolidated balance sheets in accrued expenses and other current liabilities. The non-current portion of the restructuring liabilities is included in the condensed consolidated balance sheets in other liabilities. The non-current portion of the restructuring liabilities as of June 30, 2026 and December 31, 2025 was $0.5 and $, respectively.

RestructuringAndRelatedActivitiesDisclosureTextBlock · excerpt; the full note is in the filing

Revenue recognition · 6,528 characters as filed

REVENUES The Companys revenues by geography for the three and six months ended June 30, 2026 and 2025 are as follows: Three Months Ended June 30, 2026 Three Months Ended June 30, 2025 North America Europe Other Total North America Europe Other Total Revenues $ 319.7 $ 219.7 $ 138.8 $ 678.2 $ 344.3 $ 218.7 $ 147.3 $ 710.3 Six Months Ended June 30, 2026 Six Months Ended June 30, 2025 North America Europe Other Total North America Europe Other Total Revenues $ 616.5 $ 433.6 $ 264.6 $ 1,314.7 $ 653.8 $ 419.0 $ 288.8 $ 1,361.6 Revenue from the United States comprises substantially all revenue in North America. Contract Costs The following table provides information about contract asset balances: June 30, 2026 December 31, 2025 Sales commission assets $ 18.7 $ 21.4 Deferred contract costs 0.2 0.4 Total $ 18.9 $ 21.8 Amortization related to sales commission assets for the three months ended June 30, 2026 and 2025 was $2.8 and $2.8, respectively, and for the six months ended June 30, 2026 and 2025 was $6.1 and $5.9, respectively. Amortization related to deferred contract costs for the three months ended June 30, 2026 and 2025 was $0.1 and $0.2, respectively, and for the six months ended June 30, 2026 and 2025 was $0.2 and $0.4, respectively. Th e Company applies the practical expedient to not recognize the effect of financing in its contracts with customers when the difference in timing of payment and performance is one year or less. Accounts Receivable, Unbilled Services and Unearne

RevenueFromContractWithCustomerTextBlock · excerpt; the full note is in the filing

Segment reporting · 2,799 characters as filed

BUSINESS SEGMENT INFORMATION The following table is a summary of segment information for the three and six months ended June 30, 2026 and 2025. The segment information is based upon the way the management of the Company organizes segments within an enterprise for making operating decisions and assessing performance. Financial information is reported on the basis that it is used internally by the chief operating decision maker (CODM) for evaluating segment performance and deciding how to allocate resources to segments. The Fortrea Chief Executive Officer has been identified as the CODM. The CODM allocates resources and assesses performance based on the underlying businesses which determines the Company's operating segments. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. The Company reports its business in one reportable segment: Clinical Services, which provides phase I-IV clinical trials, including clinical pharmacology and comprehensive clinical development capabilities. The measure of segment profit or loss that the CODM uses to evaluate performance and allocate resources is segment operating income. The CODM uses segment operating income to monitor budget versus actual results and to make decisions about resources to be allocated to the segment and assess its performance. In accordance with ASU 2023-07, Improvements to Reportable Segment Disclosures , significant expenses in

SegmentReportingDisclosureTextBlock · excerpt; the full note is in the filing

Stockholders' equity · 2,923 characters as filed

PREFERRED STOCK AND COMMON SHAREHOLDERS EQUITY The Company is authorized to issue up to 265.0 shares of common stock, par value $0.001 per share. The Company is authorized to issue up to 30.0 shares of preferred stock, par value $0.001 per share. There were no preferred shares outstanding as of June 30, 2026 and December 31, 2025. Stockholder Rights Plan On June 11, 2025, the Companys Board of Directors adopted a limited duration stockholder rights plan (the Rights Agreement). Pursuant to the Rights Agreement, on June 11, 2025, the Companys Board of Directors declared a dividend of one preferred share purchase right (a Right) for each share of common stock, par value $0.001 per share, of the Company (the Common Shares) outstanding on June 23, 2025 to the stockholders of record on that date. Each Right entitles the registered holder to purchase from the Company one one thousandth of a share of Series A Preferred Stock, par value $0.001 per share, of the Company (the Preferred Shares) at a price of $50.00 per one one thousandth of a Preferred Share represented by a Right, subject to adjustment. The Rights Agreement expired in accordance with its terms at the close of business on June 10, 2026. Accumulated Other Comprehensive Loss The components of accumulated other comprehensive loss are as follows: Foreign Currency Translation Adjustments Net Benefit Plan Adjustments Unrealized Gain (Loss) on Derivative Instruments Accumulated Other Comprehensive Loss Balance at December 31, 2

StockholdersEquityNoteDisclosureTextBlock · excerpt; the full note is in the filing

Source: SEC DERA Financial Statement and Notes data sets (txt.tsv), excerpts of the filer's own note text; the full note is in the linked filing. Excerpts are the first part of each note exactly as tagged in the filing; open the filing for the full text and the tables. Descriptive and educational, not advice.

Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.

Educational content only. Not financial advice. TrendNalysis provides educational and informational financial analysis built from public SEC filings and economic data (FRED, BLS). It is not financial, investment, tax, or legal advice and is not a recommendation to buy or sell any security. Market pricing is not currently included. Past performance does not guarantee future results. Always do your own research and consult a licensed financial professional before investing.